1. Home
  2. RPHM vs FEAM Comparison

RPHM vs FEAM Comparison

Compare RPHM & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPHM
  • FEAM
  • Stock Information
  • Founded
  • RPHM 2014
  • FEAM 2016
  • Country
  • RPHM United States
  • FEAM United States
  • Employees
  • RPHM N/A
  • FEAM N/A
  • Industry
  • RPHM Biotechnology: Pharmaceutical Preparations
  • FEAM Major Chemicals
  • Sector
  • RPHM Health Care
  • FEAM Industrials
  • Exchange
  • RPHM Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • RPHM 47.5M
  • FEAM 46.9M
  • IPO Year
  • RPHM 2021
  • FEAM N/A
  • Fundamental
  • Price
  • RPHM $1.82
  • FEAM $0.69
  • Analyst Decision
  • RPHM Hold
  • FEAM Buy
  • Analyst Count
  • RPHM 6
  • FEAM 4
  • Target Price
  • RPHM $2.26
  • FEAM $4.19
  • AVG Volume (30 Days)
  • RPHM 324.3K
  • FEAM 157.4K
  • Earning Date
  • RPHM 11-11-2024
  • FEAM 11-07-2024
  • Dividend Yield
  • RPHM N/A
  • FEAM N/A
  • EPS Growth
  • RPHM N/A
  • FEAM N/A
  • EPS
  • RPHM N/A
  • FEAM N/A
  • Revenue
  • RPHM N/A
  • FEAM N/A
  • Revenue This Year
  • RPHM N/A
  • FEAM N/A
  • Revenue Next Year
  • RPHM N/A
  • FEAM $1,117.19
  • P/E Ratio
  • RPHM N/A
  • FEAM N/A
  • Revenue Growth
  • RPHM N/A
  • FEAM N/A
  • 52 Week Low
  • RPHM $0.98
  • FEAM $0.40
  • 52 Week High
  • RPHM $9.21
  • FEAM $3.35
  • Technical
  • Relative Strength Index (RSI)
  • RPHM 69.89
  • FEAM 58.83
  • Support Level
  • RPHM $1.61
  • FEAM $0.45
  • Resistance Level
  • RPHM $1.75
  • FEAM $0.50
  • Average True Range (ATR)
  • RPHM 0.13
  • FEAM 0.08
  • MACD
  • RPHM 0.04
  • FEAM 0.04
  • Stochastic Oscillator
  • RPHM 87.30
  • FEAM 72.73

About RPHM Reneo Pharmaceuticals Inc.

Reneo Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is engaged boron specialty advanced materials and lithium with a focus on enabling decarbonization, including electric transportation, clean energy, and food security.

Share on Social Networks: